1. Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial. (May 2021) Authors: Thomsen, M.S.; Berg, M.; Zimmermann, S.; Lutz, C.M.; Makocki, S.; Jensen, I.; Hjelstuen, M.H.B.; Pensold, S.; Hasler, M.P.; Jensen, M.-B.; Offersen, B.V. Journal: Clinical and translational radiation oncology Issue: Volume 28(2021) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1710: Chemical stability of BioXmark® following normofractionated and single-fraction proton beam therapy. (May 2017) Authors: Troost, E.; Menkel, S.; Enghardt, W.; Hytry, J.; Kunath, D.; Makocki, S.; Hoffmann, A.; Jølck, R. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1936: Dose plan quality in the DBCG HYPO trial: an evaluation based on all treatment plans in the study. (April 2016) Authors: Thomsen, M.; Berg, M.; Zimmermann, S.; Lutz, C.; Makocki, S.; Jensen, I.; Hjelstuen, M.; Pensold, S.; Jensen, M.B.; Offersen, B. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0631 Proton and photon treatment planning comparison for oesophageal cancer between six European centres. (August 2021) Authors: Hoffmann, L.; Mortensen, H.; Berbee, M.; Bizzocchi, N.; Bütof, R.; Canters, R.; Defraene, G.; Ehmsen, M.L.; Freixas, G.V.; Haustermans, K.; Korevaar, E.W.; Makocki, S.; Muijs, C.T.; Nordsmark, M.; Thomas, M.; Troost, E.G.; Visser, S.; Weber, D.C.; Møller, D.S. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0697: Particle therapy: Assessing clinical benefit of direct stopping-power prediction from dual-energy CT. (November 2020) Authors: Peters, N.; Wohlfahrt, P.; Hofmann, C.; Möhler, C.; Makocki, S.; Richter, C. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PH-0046 Benefit of 4D robustly optimized proton plans for NSCLC patients with intrafractional motion > 5mm. (August 2021) Authors: Spautz, S.; Haase, L.; Tschiche, M.; Makocki, S.; Troost, E.G.; Richter, C.; Stützer, K. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-0946: Prospective evaluation of patient positioning for interfractional variation in proton therapy of prostate cancer. (April 2015) Authors: Schneidt, M.; Kovacevic, M.; Thiele, J.; Jakobi, A.; Haase, R.; Makocki, S.; Krause, M.; Hölscher, T.; Richter, C. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-1304 Impact of blood parameters and normal tissue dose on overall survival in esophageal cancer patients. (May 2022) Authors: Troost, E.; Häberlein, L.; Bütof, R.; Jentsch, C.; Lohaus, F.; Makocki, S.; Valentini, C.; Löck, S. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗